PRESS RELEASE published on 04/18/2025 at 09:24, 1 year 6 months ago Inside Information / Other news releases Sensorion provides preliminary documents for the Combined Shareholders' General Meeting of May 12, 2025 at Hotel Square Louvois, Paris. Shareholders can request meeting documents and view details on company website Shareholders' Meeting General Meeting Preliminary Documents Sensorion Hearing Loss
BRIEF published on 04/16/2025 at 07:35, 1 year 6 months ago Sensorion organise un symposium à la conférence ISIET 2025 Thérapie Génique Perte Auditive SENS-401 Innovations Médicales Symposium Sensorion
BRIEF published on 04/16/2025 at 07:35, 1 year 6 months ago Sensorion is organizing a symposium at the ISIET 2025 conference Gene Therapy Hearing Loss SENS-401 Medical Innovations Sensorion Symposium
PRESS RELEASE published on 04/16/2025 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Sensorion annonce un symposium lors de la conférence internationale ISIET sur les thérapies des maladies de l’oreille interne le 26 avril 2025 à Marrakech. Des interventions sur la perte auditive et thérapies géniques sont prévues Thérapies Géniques Sensorion Perte Auditive Symposium ISIET
PRESS RELEASE published on 04/16/2025 at 07:30, 1 year 6 months ago Inside Information / Other news releases Sensorion to host a symposium at ISIET's International Conference on Inner Ear Therapies in Marrakech, Morocco, on April 26, 2025, focusing on hearing loss innovation and gene therapies Sensorion Gene Therapies Symposium ISIET Inner Ear Therapies
BRIEF published on 04/02/2025 at 07:35, 1 year 7 months ago Sensorion Appoints Amit Munshi as Chairman of the Board Board Of Directors Hearing Loss Therapies Sensorion Leadership Amit Munshi Appointment Biotech Executive Experience
BRIEF published on 04/02/2025 at 07:35, 1 year 7 months ago Sensorion nomme Amit Munshi au poste de président du conseil d'administration Conseil D'administration Leadership De Sensorion Nomination D'Amit Munshi Thérapies Contre La Perte Auditive Expérience De Direction En Biotechnologie
PRESS RELEASE published on 04/02/2025 at 07:30, 1 year 7 months ago Inside Information / Other news releases Sensorion appoints Amit Munshi as Chairman of the Board and Independent Director, bringing extensive healthcare industry experience. Munshi to lead innovative therapeutic programs for hearing disorders Chairman Board Sensorion Amit Munshi Hearing Disorders
PRESS RELEASE published on 04/02/2025 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués Nomination d’Amit Munshi en tant que Président du Conseil d’Administration chez Sensorion, société de biotechnologie spécialisée dans les thérapies auditives. Annonce du départ de M. Furey Biotechnologie Conseil D'administration Sensorion Thérapies Auditives Amit Munshi
BRIEF published on 03/26/2025 at 07:35, 1 year 7 months ago Sensorion rejoint la conférence Van Lanschot Kempen à Amsterdam Biotechnologie Investisseurs Conference Sensorion Perte Auditive
Published on 10/30/2026 at 23:35, 2 days 12 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 12 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 16 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 20 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/02/2026 at 11:38, 3 minutes ago Custodian Property Income REIT plc: Total Voting Rights
Published on 11/02/2026 at 11:25, 15 minutes ago Dubai Holding Entertainment to showcase Dubai's diverse entertainment offering at WTM London 2026
Published on 11/02/2026 at 11:11, 29 minutes ago PNE sells another photovoltaic project in South Africa
Published on 11/02/2026 at 11:05, 35 minutes ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Published on 11/02/2026 at 08:40, 3 hours ago Octobre 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 10/30/2026 at 23:00, 2 days 12 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 2 days 12 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
